Genetic screening has revolutionized healthcare, offering early detection of hereditary diseases like cancer. However, ethical concerns arise when considering potential discrimination by employers or insurance companies. The video “Should We Screen for Cancer Genes?” discusses how genetic information could impact personal decisions, including preventive surgeries. While screening can save lives, it also introduces emotional and psychological burdens, such as anxiety over uncertain results.
Preimplantation genetic diagnosis (PGD), discussed in “The Ethics of Preimplantation Genetic Diagnosis,” raises additional concerns. While it allows parents to avoid passing on severe genetic conditions, it also poses moral dilemmas about “designer babies.” If used beyond medical necessity, it could lead to societal divisions based on genetic traits. Regulations should focus on preventing misuse while ensuring those who need these technologies can access them without financial barriers.
Ultimately, while genetic advancements offer hope, ethical oversight is crucial to prevent exploitation. Policies should balance innovation with ethical responsibility, ensuring that genetic screening serves public health without reinforcing inequalities.